What is the duration of antiarrhythmic therapy for Wolff-Parkinson-White (WPW) syndrome?

Updated: Jan 08, 2017
  • Author: Christopher R Ellis, MD, FACC, FHRS; Chief Editor: Mikhael F El-Chami, MD  more...
  • Print

Patients with WPW syndrome need to continue antiarrhythmic therapy as prescribed. If symptoms related to tachyarrhythmias recur, patients should inform their physicians.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!